Publications by authors named "Sumito Shingaki"

Claim this Profile
I
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis.
Kentaro Yamaguchi, Junji Koya, Kota Mizuno, Yosuke Mizukami, Kota Yoshifuji, Sumito Shingaki

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targets.
Junji Koya, Tomohiko Tanigawa, Kota Mizuno, Haryoon Kim, Yuta Ito, Sumito Shingaki

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.
Yuta Ito, Amira Marouf, Yasunori Kogure, Junji Koya, Raphaël Liévin, Sumito Shingaki

Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma.
Mariko Tabata, Yusuke Sato, Yasunori Kogure, Marni B McClure, Yuji Oshikawa-Kumade, Sumito Shingaki

Cell Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-promoting function and regulatory landscape of PD-L2 in B-cell lymphoma.
Sumito Shingaki, Junji Koya, Mitsuhiro Yuasa, Yuki Saito, Mariko Tabata

Leukemia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genetic dissection of the molecular mechanism of malignant lymphoma using advanced genomic technology].
Sumito Shingaki, Keisuke Kataoka

Rinsho Ketsueki· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
Suguru Fukuhara, Yuji Oshikawa-Kumade, Yasunori Kogure, Sumito Shingaki, Hirokazu Kariyazono

Cancer Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-genome landscape of adult T-cell leukemia/lymphoma.
Yasunori Kogure, Takuro Kameda, Junji Koya, Makoto Yoshimitsu, Kisato Nosaka, Sumito Shingaki

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1.
Junji Koya, Yuki Saito, Takuro Kameda, Yasunori Kogure, Mitsuhiro Yuasa, Sumito Shingaki

Blood Cancer Discov· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape and function of multiple mutations within individual oncogenes.
Yuki Saito, Junji Koya, Mitsugu Araki, Yasunori Kogure, Sumito Shingaki

Nature· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer.
Sumito Shingaki, Takahiro Kogawa, Mototsugu Shimokawa, Kenichi Harano, Yoichi Naito

J Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0).
Kuniko Sunami, Hideaki Takahashi, Katsuya Tsuchihara, Masayuki Takeda, Tatsuya Suzuki, Sumito Shingaki

Cancer Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[IgE-κ type multiple myeloma achieving complete response with novel agents].
Tomomi Takei, Tadao Ishida, Masahiro Ikeda, Sumito Shingaki, Kanji Miyazaki

Rinsho Ketsueki· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma.
Sumito Shingaki, Nobuhiro Tsukada, Tadao Ishida, Kenshi Suzuki

Hematol Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy].
Masahiro Ikeda, Rina Oba, Yumiko Yoshiki, Sumito Shingaki, Tomomi Takei

Rinsho Ketsueki· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis.
Sohsuke Meshitsuka, Sumito Shingaki, Masatoshi Hotta, Miku Goto, Makoto Kobayashi

Int J Hematol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexistent adrenal diffuse large B cell lymphoma in a patient with Waldenström's macrogloblinemia/lymphoplasmacytic lymphoma.
Sumito Shingaki, Yumiko Yoshiki, Kouhei Yamamoto, Yasunori Ota, Kenshi Suzuki

Ann Hematol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose melphalan and autologous stem cell transplantation for systemic light-chain amyloidosis: a single institution retrospective analysis of 40 cases.
Nobuhiro Tsukada, Masahiro Ikeda, Sumito Shingaki, Kanji Miyazaki, Sohsuke Meshitsuka

Int J Hematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The clinical significance of decrease in CD138 positive cell ratio in multiple myeloma].
Junko Inoue, Masahiro Ikeda, Sumito Shingaki, Kanji Miyazaki, Sosuke Meshitsuka

Rinsho Ketsueki· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Induction treatment with bortezomib-cyclophosphamide-dexamethasone (CyBorD) for newly diagnosed transplant-eligible patients with multiple myeloma].
Nobuhiro Tsukada, Masahiro Ikeda, Sumito Shingaki, Kanji Miyazaki, Sohsuke Meshitsuka

Rinsho Ketsueki· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Graft-versus-host disease associated with lenalidomide maintenance after allogeneic transplantation for relapsed/refractory multiple myeloma].
Nobuhiro Tsukada, Sumito Shingaki, Masahiro Ikeda, Kanji Miyazaki, Sohsuke Meshitsuka

Rinsho Ketsueki· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia].
Airi Hamano, Sumito Shingaki, Yu Abe, Kanji Miyazaki, Rieko Sekine

Rinsho Ketsueki· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis